文献速递临床试验与 GCP基础与转化研究

多模态影像测量脑血管储备用于脑动脉闭塞或狭窄患者:前瞻性随机对照临床研究方案

Measurement of cerebrovascular reserve by multimodal imaging for cerebral arterial occlusion or stenosis patients: protocol of a prospective, randomized, controlled clinical study.
PubMed 文献 · Trials · 2020-01-08

本研究为前瞻性随机对照临床试验,计划从上海交通大学医学院附属仁济医院招募66例符合条件的缺血性卒中患者,按脑血管反应性(CVR)分为CVR>10%组和CVR<10%组,再随机分配至内科管理、经皮腔内血管成形术和支架置入、颅内颅外搭桥三组(1:1:1)。主要终点为管理后6、12、24个月的所有不良事件和同侧卒中复发,次要结局包括CVR、美国国立卫生研究院卒中量表(NIHSS)和改良Rankin量表(mRS)。

要点

  • 多模态影像测量CVR可能改善缺血性卒中的治疗决策。
  • 研究按CVR>10%和CVR<10%分组,再随机分配三种治疗。
  • 主要终点为6、12、24个月不良事件和同侧卒中复发。

核心结论

  • 多模态影像测量脑血管储备指导缺血性卒中治疗的有效性和评估准确性需在随机对照环境中确立。

研究设计与样本

  • 前瞻性、随机、对照临床试验,计划招募66例来自仁济医院的缺血性卒中患者。
  • 患者按CVR分为CVR>10%组和CVR<10%组,再以1:1:1随机分配至内科管理、经皮腔内血管成形术和支架置入、颅内颅外搭桥组。

关键数值与推荐

  • 主要终点为管理后6、12、24个月的所有不良事件和同侧卒中复发。
  • 次要结局包括6、12、24个月的CVR、NIHSS和mRS。

临床怎么用

  • 多模态影像测量CVR被近期多数研究推荐用于指导缺血性卒中的治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cerebrovascular reactivity (CVR) is the change in cerebral blood flow in response to a vaso-active stimulus, and may assist the treatment strategy of ischemic stroke. However, previous studies reported that a therapeutic strategy for stroke mainly depends on the degree of vascular stenosis with steady-state vascular parameters (e.g., cerebral blood flow and CVR). Hence, measurement of CVR by multimodal imaging techniques may improve the treatment of ischemic stroke. METHODS/DESIGN: This is a prospective, randomized, controlled clinical trial that aimed to examine the capability of multimodal imaging techniques for the evaluation of CVR to improve treatment of patients with ischemic stroke. A total of 66 eligible patients will be recruited from Renji Hospital, Shanghai Jiaotong University School of Medicine. The patients will be categorized based on CVR into two subgroups as follows: CVR > 10% group and CVR < 10% group. The patients will be randomly assigned to medical management, percutaneous transluminal angioplasty and stenting, and intracranial and extra-cranial bypass groups in a 1:1:1 ratio. The primary endpoint is all adverse events and ipsilateral stroke recurrence at 6, 12, and 24 months after management. The secondary outcomes include the CVR, the National Institute of Health stroke scale and the Modified Rankin Scale at 6, 12, and 24 months. DISCUSSION: Measurement of cerebrovascular reserve by multimodal image is recommended by most recent studies to guide the treatment of ischemic stroke, and thus its efficacy and evaluation accuracy need to be established in randomized controlled settings. This prospective, parallel, randomized, controlled registry study, together with other ongoing studies, should present more evidence for optimal individualized accurate treatment of ischemic stroke. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ID: ChiCTR-IOR-16009635; Registered on 16 October 2016. All items are from the World Health Organization Trial Registration Data Set and registration in the Chinese Clinical Trial Registry: ChiCTR-IOR-16009635.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Xiao ZP, Jin K, Wan JQ, et al. Measurement of cerebrovascular reserve by multimodal imaging for cerebral arterial occlusion or stenosis patients: protocol of a prospective, randomized, controlled clinical study. Trials. 2020. PMID: 31915058. doi:10.1186/s13063-019-3967-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。